KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 152 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $82,000 | -41.4% | 11,335 | -52.5% | 0.00% | -33.3% |
| Q4 2016 | $140,000 | -32.4% | 23,870 | -38.7% | 0.00% | -40.0% |
| Q3 2016 | $207,000 | -48.1% | 38,949 | -54.4% | 0.01% | -54.5% |
| Q1 2016 | $399,000 | +50.0% | 85,452 | +62.4% | 0.01% | +120.0% |
| Q4 2015 | $266,000 | +491.1% | 52,634 | +312.8% | 0.01% | +400.0% |
| Q3 2015 | $45,000 | -78.9% | 12,751 | -40.2% | 0.00% | -75.0% |
| Q2 2015 | $213,000 | -28.5% | 21,321 | -9.0% | 0.00% | -33.3% |
| Q1 2015 | $298,000 | +19.2% | 23,436 | +32.8% | 0.01% | +50.0% |
| Q4 2014 | $250,000 | -7.4% | 17,645 | +0.4% | 0.00% | 0.0% |
| Q2 2014 | $270,000 | -28.0% | 17,580 | -52.6% | 0.00% | -20.0% |
| Q3 2013 | $375,000 | – | 37,126 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Old West Investment Management, LLC | 1,068,719 | $3,633,000 | 1.50% |
| Abrams Capital Management | 9,108,867 | $30,970,000 | 0.82% |
| Baupost Group | 25,791,678 | $87,692,000 | 0.67% |
| Bristol Advisors, LLC | 51,100 | $174,000 | 0.29% |
| RICE HALL JAMES & ASSOCIATES, LLC | 2,228,059 | $7,575,000 | 0.27% |
| NEXTHERA CAPITAL LP | 200,000 | $680,000 | 0.13% |
| LINCOLN CAPITAL CORP | 37,280 | $127,000 | 0.10% |
| Meridian Wealth Management, LLC | 49,600 | $169,000 | 0.07% |
| Rubric Capital Management LP | 199,883 | $680,000 | 0.07% |
| Virtus ETF Advisers LLC | 155,009 | $527,000 | 0.05% |